IUC26661-86

Abstract Code: IUC26661-86   Real-world outcomes in patients with Metastatic Hormone-Sensitive Prostate Cancer treated with androgen deprivation therapy and Apalutamide – A single centre study Marchon 1, S. Brown 1, K. Swaminathan 1, S. Adeyemi 1, G. Kapur...

IUC26659-93

Abstract Code: IUC26659-93   Transdermal Estradiol as an Alternative to LHRH Agonists in Prostate Cancer Management Khanna 1, S. Debra 1, D. Sethi 1, M. Abdel-Missih 1 (1) The University of Buckingham Medical School, Crewe – United Kingdom  ...

IUC26655-89

Abstract Code: IUC26655-89   Pretreatment Hemoglobin-Albumin-Lymphocyte-Platelet Score, Dosimetry, and Acute Toxicity After Definitive Prostate Radiotherapy: Interim Real-World Evidence Depboylu 1, T. Bahceci 2, H. Onder 3, Y. Yalcin 4 (1) Aydin Adnan Menderes...

IUC26651-85

Abstract Code: IUC26651-85   AI-assisted Biparametric vs Multiparametric MRI for Clinically Significant Prostate Cancer Tiwari 1, K. Bhagat 2, U. Khan 3, J.K. Tan 4, D. Sethi 5, A. Maniam 6, G. Banna 7, A. Khan 8, A. Ghose 1 (1) Cancer AI Validation Lab, OncoFlow...

IUC26648-91

Abstract Code: IUC26648-91   Cost-effectiveness of Intensity-Modulated Radiation Therapy versus Robot-Assisted Radical Prostatectomy in Patients with Prostate Cancer: A Systematic Review Septiani 1, N.P. Ayuningtyas 1 (1) Raden Mattaher Regional Hospital Jambi....

IUC26645-88

Abstract Code: IUC26645-88   Challenges of AI in Surgical Planning for Radical Prostatectomy: Barriers and Progress Rajaee Rizi 1, M.S. Jamadi 2 (1) Endocrine and Metabolism Research Center, Isfahan University of Medical Sciences, Isfahan, Iran – Iran,...
error: Content is protected !!